IRAG
DXCM icon

Investment Research & Advisory Group’s DexCom DXCM Stock Holding History

Investment Research & Advisory Group’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.07K Hold
100
– – ﹤0.01% 252
2026
Q1 		$7.03K Hold
100
– – ﹤0.01% 211
2025
Q4 		$7.1K Hold
100
– – ﹤0.01% 208
2025
Q3 		$7.27K Hold
100
– – ﹤0.01% 192
2025
Q2 		$8.73K Hold
100
– – ﹤0.01% 177
2025
Q1 		$6.83K Hold
100
– – ﹤0.01% 182
2024
Q4 		$7.78K Hold
100
– – ﹤0.01% 164
2024
Q3 		$6.7K Hold
100
– – ﹤0.01% 167
2024
Q2 		$11.3K Hold
100
– – 0.01% 148
2024
Q1 		$13.9K Hold
100
– – 0.01% 144
2023
Q4 		$12.4K Hold
100
– – 0.01% 140
2023
Q3 		$9.33K Hold
100
– – 0.01% 148
2023
Q2 		$12.9K Hold
100
– – 0.01% 148
2023
Q1 		$11.6K Hold
100
– – 0.01% 132
2022
Q4 		$11.3K Hold
100
– – 0.01% 131
2022
Q3 		$8K Hold
100
– – 0.01% 141
2022
Q2 		$7K Buy
+100
New +$9.13K 0.01% 152

Other funds holding DXCM

SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
FFM
Fisher Funds Management Auckland, New Zealand $3.52B AUM 17.59% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
PCM
Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return
FMI
Factory Mutual Insurance Waltham, Massachusetts $10.6B AUM 34.1% 1-Year Est. Return
OIAM
OFI Invest Asset Management Paris, France $10B AUM 48.47% 1-Year Est. Return
AS
Aware Super Sydney, Australia $7.06B AUM
GI
Gradient Investments Arden Hills, Minnesota $7.25B AUM 20.71% 1-Year Est. Return

Investment Research & Advisory Group's DXCM Position: Q2 2026 in Review

Investment Research & Advisory Group held its DexCom (DXCM) position steady in Q2 2026 at 100 shares worth $7.07K. The position accounts for ﹤0.01% of the portfolio, ranked #252.

Investment Research & Advisory Group first reported a position in DXCM in Q2 2022 and has held it in 17 quarters since. The position peaked at $13.9K in Q1 2024. 307 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • Investment Research & Advisory Group held 100 shares of DexCom worth $7.07K as of Q2 2026.
  • Investment Research & Advisory Group left its DexCom share count unchanged in Q2 2026.
  • DexCom made up ﹤0.01% of Investment Research & Advisory Group's portfolio in Q2 2026, its #252 holding.
  • Investment Research & Advisory Group first reported a position in DexCom in Q2 2022 and has held it in 17 quarters since.
  • Investment Research & Advisory Group's DexCom position peaked at $13.9K in Q1 2024.
  • 307 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Investment Research & Advisory Group's 13F filing for Q2 2026, filed 23 Jul 2026.